Skip to main content
Log in

Characteristics of end stage renal disease diabetic patients in two countries with different socioeconomic conditions

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose: To identify differences that may affect morbidity and mortality of type 2 diabetic patients reaching ESRD between countries with different socioeconomic conditions. Methods: Comparison of clinical and laboratory features between 21 Nigerian (N) and 57 American patients (A) reaching ESRD over a 30month period. Results: Differences were noted in age at ESRD (N, 55.5±9.8; A, 64.5±9.6years), duration of diabetes (N, 5.2±2.8, A: 14.9±4.9years), body mass index (N, 24.5±4.1; A; 27.6±6.3kg/m2), prevalence of left ventricular hypertrophy (N; 14%; A, 89%) and ischemic heart disease (N, 26%; A, 67%), blood pressure (N, [166.2±26.7]/[98.6±16.5]mmHg; A, [146.8±23.6]/[72.5±13.3]mmHg), creatinine clearance (N, 6.1±3.6; A, 14.8±3.5ml/min), urine protein excretion (N, 1.2±0.7; A, 6.1±4.9g/24-h), hematocrit (N, 28.0±6.0; A, 35.0±5.0%), serum glucose (N, 5.6±1.6; A, 10.5±5.5mmol/l), and serum cholesterol (N, 5.32±2.57; A, 4.19±1.16mmol/l) (all at P≤0.05). Differences were also found in the number of antihypertensive medications (N 1.4±0.6; A 2.4±1.2 per patient), and use of medications for diabetes (N 29%, A 79%), statins (N zero, A 61%) and erythropoietin (N zero, A 39%). 72% of the A, but none of the N patients had a functional dialysis access prior to ESRD. Conclusions: Between A and N patients reaching ESRD, there are differences in clinical features and laboratory values that may affect morbidity, mortality and impact on the health care resources. These differences indicate areas where further studies that could assist in the planning for ESRD care in both Nigeria and USA are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • U.S. Renal Data System, USRDS Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2000.

  • E Ritz I Rychlik F Locatelli S Halimi (1999) ArticleTitleEnd-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimension. Am J Kidney Dis 34 795–808

    Google Scholar 

  • IE Agaba OO Agbaji EA Anteyi (2002) ArticleTitlePattern of renal disease in North Central Nigeria. J Med in Tropics 4 33–37

    Google Scholar 

  • CO Alebiosu (2003) ArticleTitleClinical diabetic nephropathy in a tropical African population. West Afr J Med 22 152–155

    Google Scholar 

  • TWG Kinnear (2002) ArticleTitleThe pattern of diabetes in a Nigerian teaching hospital. East Afr Med J 40 288–294

    Google Scholar 

  • A Adetuyibi (1976) ArticleTitleDiabetes in Nigerian African. I: Review of long-term complications Trop Geog Med 28 155–168

    Google Scholar 

  • FS Wokoma (1988) ArticleTitleThe clinical profile of Nigerians with long-standing diabetes mellitus. Int Diab Dig 9 44–45

    Google Scholar 

  • IE Agaba EA Anteyi FH Puepet PA Omudu JA Idoko (2002) ArticleTitleThe clinical pattern of diabetic nephropathy in type 2 diabetes mellitus in North Central Nigeria. J Med in Tropics 4 10–14

    Google Scholar 

  • CE Mogensen CK Chistensen E Vittinghus (1983) ArticleTitleThe stages in diabetic renal disease: With emphasis on the stage of incipient nephropathy. Diabetes 32 IssueIDSuppl 2 64–78

    Google Scholar 

  • BL Kassiske RSN Kalil JZ Ma et al. (1993) ArticleTitleEffect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118 129–138

    Google Scholar 

  • InstitutionalAuthorNameUKPDS Group (1998) ArticleTitleIntensive blood glucose control with sulfonynureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837–853

    Google Scholar 

  • LF Fried TJ Orchard B Kassiske (2001) ArticleTitleThe effect of lipid reduction on renal disease progression: A meta analysis. Kidney Int 59 260–269

    Google Scholar 

  • DW Cockroft MH Gault (1976) ArticleTitlePrediction of creatinine clearance from serum creatinine. Nephron 16 31–41 Occurrence Handle1:STN:280:CSmD2srptFU%3D Occurrence Handle1244564

    CAS  PubMed  Google Scholar 

  • W Owen J Roberts S Alexander et al. (2001) ArticleTitleNational Kidney Foundation, K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, 2000. Am J Kidney Dis 37 IssueIDSuppl 1 S7–S64

    Google Scholar 

  • TA Golper D Churchill P Blake et al. (2001) ArticleTitleNational Kidney Foundation. K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, 2000 Am J Kidney Dis 37 IssueIDSuppl 1 S65–S136 Occurrence Handle11229968

    PubMed  Google Scholar 

  • S Schwab A Besarab G Beathard et al. (2001) ArticleTitleNational Kidney Foundation. K/DOQI Clinical Practice Guidelines for Vascular Access, 2000 Am J Kidney Dis 37 IssueIDSuppl. 1 S137–S181

    Google Scholar 

  • J Eschbach P Oreo ParticleDe J Abramson et al. (2001) ArticleTitleNational Kidney Foundation. K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2000 Am J Kidney Dis 37 IssueIDSuppl. 1 S182–S238 Occurrence Handle11229970

    PubMed  Google Scholar 

  • The Management of Kidney Failure Work Group: Veterans Health Administration/Department of Defense Clinical Practice Guideline for the Management of Chronic Kidney Disease and pre-ESRD in the Primary Care Setting. August 2000. Revised 2001, Version 1.1.

  • AS Levey J Coresh K Bolton et al. (2002) ArticleTitleNational Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39 IssueIDSuppl. 1 S1–S266

    Google Scholar 

  • CE Mogensen (1982) ArticleTitleDiabetes and the kidney Kidney Int 21 673–674

    Google Scholar 

  • N Ismail B Becker P Strzelczyk E Ritz (1999) ArticleTitleRenal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 55 1–28 Occurrence Handle10.1046/j.1523-1755.1999.00232.x Occurrence Handle1:STN:280:DyaK1M7htFCltg%3D%3D Occurrence Handle9893112

    Article  CAS  PubMed  Google Scholar 

  • S Bosseri SA Beshyah (2001) ArticleTitleCharacteristics of diabetic patients with end-stage renal failure on chronic hemodialysis in Tripoli, Libya. Diabetes Int 21 19–21

    Google Scholar 

  • CO Alebiosu O Odusan A Jaiyesimi (2003) ArticleTitleMorbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients. J Natl Med Assoc 95 1042–1047

    Google Scholar 

  • BD Myers RG Nelson GW Williams et al. (1991) ArticleTitleGlomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88 524–530

    Google Scholar 

  • JJ Dillon (1993) ArticleTitleThe quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis 22 798–802

    Google Scholar 

  • CE Mogensen (1998) ArticleTitleCombined blood pressure and glucose in type 2 diabetes mellitus: double jeopardy: British trial shows clear effects of treatment, especially blood pressure reduction. Br Med J 317 693–694

    Google Scholar 

  • HR Jacobson GE Striker (1995) ArticleTitleReport on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 25 103–106

    Google Scholar 

  • E Ritz SR Orth (1999) ArticleTitleNephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341 1127–1133

    Google Scholar 

  • ME Molitch RA DeFronzo MJ Franz WF Keane CE Mogensen HH Parving et al. (2002) ArticleTitleAmerican Diabetes Association. Diabetic nephropathy. Diabetes Care 25 IssueIDSuppl 1 S85–S89

    Google Scholar 

  • PG Zager J Nicolic RH Brown et al. (1998) ArticleTitle“U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54 561–569

    Google Scholar 

  • HH Parving H Lehnert J Brochner-Mortensen et al. (2001) ArticleTitleThe effect of irbersartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 870–878 Occurrence Handle10.1056/NEJMoa011489 Occurrence Handle1:CAS:528:DC%2BD3MXntlelsLY%3D Occurrence Handle11565519

    Article  CAS  PubMed  Google Scholar 

  • RB Devereux (1990) ArticleTitleIs the electrocardiogram still useful for detection of left ventricular hypertrophy? Circulation 81 1144–1145

    Google Scholar 

  • MA Araoye (1996) ArticleTitleLeft ventricular hypertrophy by ECG: A code system applicable to Negroes. Nig Postgrad Med J 3 92–97

    Google Scholar 

  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

    Google Scholar 

  • Ritz E 35 (2002) ArticleTitleConsequences of late referral in diabetic renal disease. Acta Diabetol 39 IssueID(Suppl 1) S3–S8

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emmanuel I. Agaba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agaba, E.I., Adeniyi, O., Servilla, K.S. et al. Characteristics of end stage renal disease diabetic patients in two countries with different socioeconomic conditions. Int Urol Nephrol 36, 611–616 (2004). https://doi.org/10.1007/s11255-004-2078-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-004-2078-4

Keywords

Navigation